Alx Oncology Holdings Stock Price Prediction

ALXO Stock  USD 16.08  1.59  10.97%   
As of today, the relative strength index (RSI) of Alx Oncology's share price is approaching 40. This suggests that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Alx Oncology, making its price go up or down.

Oversold Vs Overbought

40

 
Oversold
 
Overbought
Alx Oncology Holdings stock price prediction is an act of determining the future value of Alx Oncology shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Alx Oncology's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Alx Oncology and does not consider all of the tangible or intangible factors available from Alx Oncology's fundamental data. We analyze noise-free headlines and recent hype associated with Alx Oncology Holdings, which may create opportunities for some arbitrage if properly timed.
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Alx Oncology based on different types of headlines from major news networks to social media. The Alx stock price prediction module provides an analysis of price elasticity to changes in media outlook on Alx Oncology over a specific investment horizon. Using Alx Oncology hype-based prediction, you can estimate the value of Alx Oncology Holdings from the perspective of Alx Oncology response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Alx Oncology. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Alx Oncology to buy its stock at a price that has no basis in reality. In that case, they are not buying Alx because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Alx Oncology after-hype prediction price

    
  USD 16.08  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Alx Oncology Basic Forecasting Models to cross-verify your projections.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Alx Oncology's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
7.3112.5317.75
Details
Naive
Forecast
LowNextHigh
11.6916.9122.13
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
11.7214.5117.31
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Alx Oncology. Your research has to be compared to or analyzed against Alx Oncology's peers to derive any actionable benefits. When done correctly, Alx Oncology's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Alx Oncology Holdings.

Alx Oncology After-Hype Price Prediction Density Analysis

As far as predicting the price of Alx Oncology at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Alx Oncology or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Alx Oncology, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Alx Oncology Estimiated After-Hype Price Volatility

In the context of predicting Alx Oncology's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Alx Oncology's historical news coverage. Alx Oncology's after-hype downside and upside margins for the prediction period are 10.86 and 21.30, respectively. We have considered Alx Oncology's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
16.08
16.08
After-hype Price
21.30
Upside
Alx Oncology is somewhat reliable at this time. Analysis and calculation of next after-hype price of Alx Oncology Holdings is based on 3 months time horizon.

Alx Oncology Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Alx Oncology is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Alx Oncology backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Alx Oncology, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.43 
5.22
 0.00  
  0.03 
0 Events / Month
5 Events / Month
In 5 to 10 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
16.08
16.08
0.00 
0.00  
Notes

Alx Oncology Hype Timeline

Alx Oncology Holdings is presently traded for 16.08. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.03. Alx is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is presently at 0.43%. %. The volatility of related hype on Alx Oncology is about 7006.71%, with the expected price after the next announcement by competition of 16.05. About 98.0% of the company shares are held by institutions such as insurance companies. The book value of Alx Oncology was presently reported as 3.8. The company recorded a loss per share of 3.74. Alx Oncology Holdings had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in 5 to 10 days.
Check out Alx Oncology Basic Forecasting Models to cross-verify your projections.

Alx Oncology Related Hype Analysis

Having access to credible news sources related to Alx Oncology's direct competition is more important than ever and may enhance your ability to predict Alx Oncology's future price movements. Getting to know how Alx Oncology's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Alx Oncology may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
CABACabaletta Bio 0.00 0 per month 0.00 (0.09) 6.24 (7.00) 17.98 
VIRXViracta Therapeutics 0.00 0 per month 7.39  0.15  11.76 (9.35) 49.28 
EYPTEyepoint Pharmaceuticals 0.00 0 per month 0.00 (0.03) 5.87 (4.95) 15.45 
BMEABiomea Fusion(0.96)9 per month 0.00 (0.06) 9.40 (9.67) 30.14 
CRNXCrinetics Pharmaceuticals 0.83 8 per month 2.77  0.07  5.36 (5.47) 26.28 
IMTXImmatics NV 0.00 0 per month 0.00 (0.1) 3.34 (3.32) 11.52 
BCABBioatlaInc 0.00 0 per month 5.79  0.08  14.88 (8.96) 38.15 
AVTEAerovate Therapeutics 0.00 0 per month 4.89  0.05  11.11 (6.86) 28.53 
DYNDyne TherapeuticsInc(0.93)9 per month 3.51  0.15  6.42 (6.11) 26.24 
EWTXEdgewise Therapeutics 0.99 10 per month 3.16  0.13  7.13 (5.89) 45.27 
CGEMCullinan Oncology LLC(0.70)11 per month 2.54  0.21  7.82 (4.55) 23.70 
STOKStoke Therapeutics(0.78)7 per month 4.52  0.16  22.86 (8.17) 63.72 
MLYSMineralys Therapeutics Common 0.00 0 per month 2.55  0.13  6.29 (4.25) 24.22 
IPSCCentury Therapeutics 0.00 0 per month 0.00 (0.06) 8.37 (9.48) 32.09 
CCCCC4 TherapeuticsInc 0.00 0 per month 4.28  0.06  11.94 (7.09) 32.75 
TCRRTcr2 Therapeutics 0.06 8 per month 3.26  0.06  5.77 (6.25) 43.60 
RVMDRevolution Medicines 0.00 0 per month 2.00  0.18  4.21 (3.82) 14.22 
BDTXBlack Diamond Therapeutics 0.00 0 per month 4.22  0.20  15.50 (7.18) 26.97 
BCELAtreca Inc 0.00 0 per month 0.00 (0.17) 16.00 (15.38) 83.93 
PASGPassage Bio 0.00 0 per month 4.10  0.11  9.68 (6.43) 41.15 

Alx Oncology Additional Predictive Modules

Most predictive techniques to examine Alx price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Alx using various technical indicators. When you analyze Alx charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Alx Oncology Predictive Indicators

The successful prediction of Alx Oncology stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Alx Oncology Holdings, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Alx Oncology based on analysis of Alx Oncology hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Alx Oncology's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Alx Oncology's related companies.

Story Coverage note for Alx Oncology

The number of cover stories for Alx Oncology depends on current market conditions and Alx Oncology's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Alx Oncology is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Alx Oncology's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Alx Oncology Short Properties

Alx Oncology's future price predictability will typically decrease when Alx Oncology's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Alx Oncology Holdings often depends not only on the future outlook of the potential Alx Oncology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Alx Oncology's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding43 M
Cash And Short Term Investments182.7 M
When determining whether Alx Oncology Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Alx Oncology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Alx Oncology Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Alx Oncology Holdings Stock:
Check out Alx Oncology Basic Forecasting Models to cross-verify your projections.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Complementary Tools for Alx Stock analysis

When running Alx Oncology's price analysis, check to measure Alx Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alx Oncology is operating at the current time. Most of Alx Oncology's value examination focuses on studying past and present price action to predict the probability of Alx Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alx Oncology's price. Additionally, you may evaluate how the addition of Alx Oncology to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bonds Directory
Find actively traded corporate debentures issued by US companies
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Fundamental Analysis
View fundamental data based on most recent published financial statements
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Is Alx Oncology's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alx Oncology. If investors know Alx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alx Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Alx Oncology Holdings is measured differently than its book value, which is the value of Alx that is recorded on the company's balance sheet. Investors also form their own opinion of Alx Oncology's value that differs from its market value or its book value, called intrinsic value, which is Alx Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alx Oncology's market value can be influenced by many factors that don't directly affect Alx Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alx Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alx Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alx Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.